Eculizumab and Splenectomy as Salvage Therapy for Severe Antibody-Mediated Rejection After HLA–Incompatible Kidney Transplantation-Reference-Cited by-同舟云学术

Eculizumab and Splenectomy as Salvage Therapy for Severe Antibody-Mediated Rejection After HLA–Incompatible Kidney Transplantation

Published:2014-10-27 Issue:8 Volume:98 Page:857-863
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Orandi Babak J.,Zachary Andrea A.,Dagher Nabil N.,Bagnasco Serena M.,Garonzik-Wang Jacqueline M.,Van Arendonk Kyle J.,Gupta Natasha,Lonze Bonnie E.,Alachkar Nada,Kraus Edward S.,Desai Niraj M.,Locke Jayme E.,Racusen Lorraine C.,Segev Dorry L.,Montgomery Robert A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference22 articles.

1. Desensitization in HLA-incompatible kidney recipients and survival.;Montgomery;N Engl J Med,2011

2. Positive cross-match living donor kidney transplantation: longer-term outcomes.;Haririan;Am J Transplant,2009

3. Transplant glomerulopathy.;Cosio;Am J Transplant,2008

4. Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels.;Issa;Transplantation,2008

5. Rituximab as treatment for refractory kidney transplant rejection.;Becker;Am J Transplant,2004

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Alloantibodies on Clinical VCA Outcomes and the Need for Immune Tolerance;Transplantology;2024-07-29

2. Characteristics of Early Antibody Mediated Rejection in Antibody Incompatible Living Donor Kidney Transplantation;Transplant International;2024-07-08

3. Sequential administration of anti-complement component C5 eculizumab and type-2 anti-CD20 obinutuzumab for the treatment of early antibody-mediated rejection after kidney transplantation: A proof of concept;Clinical Immunology;2024-07

4. The role of anticomplement therapy in the management of the kidney allograft;Clinical Transplantation;2024-03

5. Thrombotic Microangiopathy in ABO-incompatible Kidney Transplant – Eculizumab to the Rescue;Indian Journal of Transplantation;2024-01